The Genetic Influence of the Nonclassical MHC Molecule HLA-G on Multiple Sclerosis

Human Immunology

Volumn 68, Issue 5, 2007, Pages 422-425

  Kroner, Antje ^a   Grimm, Alexander ^a   Johannssen, Kirsten ^a   Mäurer, Mathias ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

genetic variation; HLA G; Multiple Sclerosis; Nonclassical MHC molecule; polymorphism

Indexed keywords

HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CODON, NONSENSE; EXONS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 34247234404     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.01.012     Document Type: Article

References (30)

1. Sadovnick A.D., Baird P.A., and Ward R.H. Multiple sclerosis: updated risks for relatives. Am J Med Genet 29 (1988) 533
2. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., and Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13 (1996) 464
3. Carton H., Vlietinck R., Debruyne J., De Keyser J., D'Hooghe M.B., Loos R., Medaer R., Truyen L., Yee I.M., and Sadovnick A.D. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 62 (1997) 329
4. Dyment D.A., Ebers G.C., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol (2004) 3104
5. Heinrichs H., and Orr H.T. HLA non-A,B,C class I genes: their structure and expression. Immunol Res 9 (1990) 265
6. Rodgers J.R., and Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol 5 (2005) 459
7. Wiendl H., Behrens L., Maier S., Johnson M.A., Weiss E.H., and Hohlfeld R. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann Neurol 48 (2000) 679
8. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., and Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?. Am J Pathol 159 (2001) 71
9. Wiendl H., Feger U., Mittelbronn M., Jack C., Schreiner B., Stadelmann C., Antel J., Brueck W., Meyermann R., Bar-Or A., Kieseier B.C., and Weller M. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128 (2005) 2689
10. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., and Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186 (1997) 289
11. Mallet V., Blaschitz A., Crisa L., Schmitt C., Fournel S., King A., Loke Y.W., Dohr G., and Le Bouteiller P. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 11 (1999) 889
12. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., and Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 (2003) 1039-1044
13. Carosella E.D., Moreau P., Aractingi S., and Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 22 (2001) 553
14. H. Wiendl H. HLA-G in the nervous system. Hum Immunol. In press, 2007.
15. Ober C., Aldrich C.L., Chervoneva I., Billstrand C., Rahimov F., Gray H.L., and Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 72 (2003) 1425
16. Casro M.J., Morales P., Rojo-Amigo R., Martinez-Laso J., Allende L., Varela P., Garcia-Berciano M., Guillen-Perales J., and Arnaiz-Villena A. Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens 56 (2000) 232
17. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., and Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81 (2003) 199
18. Ober C., Aldrich C., Rosinsky B., Robertson A., Walker M.A., Willadsen S., Verp M.S., Geraghty D.E., and Hunt J.S. HLA-G1 protein expression is not essential for fetal survival. Placenta 19 (1998) 127
19. Le Discorde M., Le Danff C., Moreau P., Rouas-Freiss N., and Carosella E.D. HLA-G*0105N null allele encodes functional HLA-G isoforms. Biol Reprod 73 (2005) 280
20. Pfeiffer K.A., Fimmers R., Engels G., van der Ven H., and van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 7 (2001) 373
21. Aldrich C.L., Stephenson M.D., Karrison T., Odem R.R., Branch D.W., Scott J.R., Schreiber J.R., and Ober C. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 7 (2001) 1167
22. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., and Moreau P. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64 (2003) 1005
23. Rizzo R., Hviid T.V., Stignani M., Balboni A., Grappa M.T., Melchiorri L., and Baricordi O.R. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 57 (2005) 172
24. Tripathi P., Abbas A., Naik S., and Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64 (2004) 706
25. Hviid T.V., Milman N., Hylenius S., Jakobsen K., Jensen M.S., and Larsen L.G. HLA-G polymorphisms and HLA-G expression in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 (2006) 30 (a)
26. Kroner A., Mehling M., Hemmer B., Rieckmann P., Toyka K.V., Maurer M., and Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58 (2005) 50
27. Hviid T.V., Hylenius S., Hoegh A.M., Kruse C., and Christiansen O.B. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60 (2002) 122
28. Mitsdoerffer M., Schreiner B., Kieseier B.C., Neuhaus O., Dichgans J., Hartung H.P., Weller M., and Wiendl H. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol 159 (2005) 155
29. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 19 (2005) 681
30. Hviid T.V., Rizzo R., Melchiorri L., Stignani M., and Baricordi O.R. Polymorphism in the 5′ upstream regulatory and 3′ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 67 (2006) 53 (b)